Clinical Trials Browser

Unknown × INDUSTRY × SHR-1701 × Clear all

NCT04580498 2023-05-19

A Trial of SHR-1701 With or Without Chemotherapy in Patients With Stage III NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT03774979 2022-11-08

SHR-1701 in Subjects With Metastatic or Locally Advanced Solid Tumors

Phase 1 Unknown

Neoplasm Metastasis

NCT05198817 2022-06-28

A Trial of SHR-2002 Injection or Combined With Other Anti-cancer Medication in Advanced Malignant Tumors of Patients

Phase 1 Unknown

Advanced Malignant Tumors

NCT04679038 2022-01-26

A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor

NCT04282070 2021-12-21

SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Phase 1 Unknown

Nasopharyngeal Carcinoma

NCT05132413 2021-11-24

A Study of SHR-1701 Plus Bevacizumab and Chemotherapy in Non-Small-Cell-Lung-Cancer

Phase 3 Unknown

Advanced or Metastatic Non-squamous Non-small-cell Lung Cancer

NCT03710265 2021-11-22

SHR-1701 in Metastatic or Locally Advanced Solid Tumors

Phase 1 Unknown

Neoplasm Metastasis

NCT04650633 2021-10-29

SHR-1701 in Patients With Recurrent/Metastatic Scchn

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck

NCT05020925 2021-08-25

SHR-1701 in Combination With Famitinib in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Phase 1/2 Unknown

Nasopharyngeal Carcinoma

NCT04884009 2021-05-12

A Trial of SHR-1701 in Combination With and Without Famitinib Malate in Patients With Extensive Stage Small Cell Lung Cancer

Phase 2 Unknown

Lung Neoplasms